Q1FY27 Results: Revenue Up 13% YoY to Rs 12,654m; EBITDA at Rs 2,298m

Ebitda Margin CompressionExceptional ItemPat Growth 25pctResults View source PDF Explain this filing

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹1076.30

prior close

₹1060.80

announcement price

In-mkt

timing

Nifty Microcap 250market+1.1%-6.0% vs market

Pharmaceuticals peers, median of 164sector+0.1%-5.1% vs sector

On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 5.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.2

15m

-3.5

30m

-3.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+1.1-6.0+0.1-5.1

Next day

-4.8+2.4-7.3+1.1-5.9

-8.9+2.9-11.8+1.0-10.0

-10.1+4.2-14.3+1.1-11.2

-7.2+4.6-11.8+1.2-8.4

-6.9+4.6-11.5+1.5-8.4

-6.6+4.4-11.0+2.3-8.9

15d

-8.6+5.7-14.3+1.3-9.9

-4.4+6.6-10.9+2.3-6.7

+3.2+5.4-2.2+3.0+0.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Strides reported Q1FY27 revenue at Rs 12,654m, up 13% YoY, led by 17% YoY growth in Ex-US markets (Rs 5,875m). US business was steady at Rs 6,282m, up 4% YoY. EBITDA grew 5.4% YoY to Rs 2,298m despite about Rs 131m geopolitical cost impact; margin compressed 130 bps to 18.2%. Operational PAT rose 8% to Rs 1,231m. Reported PAT jumped 56.7% to Rs 1,655m, aided by a Rs 1,000m gain from Pivot Path divestment. Net debt fell Rs 119m; Net Debt/EBITDA at 1.52x.

Likely market impact

Steady revenue growth and strong Ex-US performance are positives, but margin compression signals ongoing cost pressures. Exceptional gain lifts reported PAT.